This website uses its own and third-party cookies in order to improve the browsing experience. If you continue browsing you will be accepting expressly the use of these cookies. You can get more information on our Cookies policy page.
Accept

NEWS

04/01/2019

OSASEN obtains the Operating License for Medical Devices from the Spanish Agency of Medicines and Medical Devices

OSASEN has recently obtained from the Spanish Agency of Medicines and Medical Devices the Operating License for Medical Devices.

With this License, OSASEN takes an important step in its business project by obtaining authorization as a manufacturer of its OSAXYL® system consisting of the OSAXYL Xylometer 700 meter device and the OSAXYL test strips.

OSAXYL is a Point of Care (PoC) system for the detection of xylose in urine, which has been validated, guaranteeing its high level of precision and reliability.

The OSASEN enzyme biosensors based on electrochemical detection are a powerful alternative for its application to PoC devices, since they combine the high specificity of the enzymes, with mass production techniques of miniaturized devices. This technological application derives from a patent recently registered by OSASEN.

OSAXYL will improve the health and well-being of people with lactose intolerance, allowing a comfortable, quick and easy diagnosis, as well as a reduction in health costs.

For this purpose OSAXYL will be used in combination with the diagnostic medicine LacTEST® developed by VENTER PHARMA and marketed by FERRER.

Equipo osaxyl